Screener
Bio-Techne TECH Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056302
| Line item | March 31, 2026 / (unaudited) | June 30, 2025 |
|---|---|---|
| Total current liabilities | 153,278 | 175,849 |
| Deferred income taxes | 14,210 | 6,169 |
| Long-term debt obligations | 200,000 | 346,000 |
| Operating lease liabilities | 76,141 | 83,960 |
| Other long-term liabilities | 21,668 | 27,082 |
| Shareholders’ equity: | ||
| Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding | — | — |
| Common stock, par value $.01 per share; authorized 400,000,000; issued and outstanding 156,516,091 and 154,972,196 respectively | 1,565 | 1,550 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Bio-Techne's operating lease liabilities?
- Bio-Techne (TECH) reported operating lease liabilities of $76.14M in Q1 2026.
- How has Bio-Techne's operating lease liabilities changed year-over-year?
- Bio-Techne's operating lease liabilities decreased by 4.2% year-over-year, from $79.45M to $76.14M.
- What is the long-term trend for Bio-Techne's operating lease liabilities?
- Over 4 years (2021 to 2025), Bio-Techne's operating lease liabilities has grown at a 5.6% compound annual growth rate (CAGR), from $67.63M to $83.96M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Bio-Techne's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude